Postoperative Pain Model Development Service
Are you currently facing long drug development cycles, challenges in validating novel analgesics, or difficulty translating preclinical findings to clinical success? Our postoperative pain models service helps you accelerate drug discovery, obtain highly predictive preclinical data, and streamline your validation processes through robust preclinical models, comprehensive phenotyping, and expert scientific consultation. We deliver the insights needed to bring effective pain therapies to patients faster.
Postoperative pain models are indispensable tools in modern drug discovery, serving as critical bridges between basic science and clinical application. They allow researchers to simulate the complex physiological responses to surgical trauma in a controlled environment, providing a platform for identifying and validating novel analgesic compounds. These models are crucial for understanding pain mechanisms and for developing non-opioid therapeutics that address the multifaceted nature of post-surgical pain and its potential progression to chronic states. Their reliability and translational relevance are paramount for accelerating the journey from drug candidate to patient benefit.
How Our Postoperative Pain Models Can Assist Your Project
At Creative Biolabs, we provide comprehensive solutions for evaluating novel analgesic compounds in a range of meticulously validated postoperative pain models. Our services are designed to deliver clear, actionable data that supports critical go/no-go decisions in your drug development pipeline. We ensure your research is grounded in relevant biological mechanisms, leading to higher confidence in clinical translation.
Discover How We Can Help - Request a Consultation Today to discuss your specific needs and timeline.
Workflow:
Our collaborative approach ensures a seamless and transparent research process, from initial concept to final data delivery.
- Required Starting Materials: To initiate your project, we typically require:
- Target Compound Details: Information on your test compound(s), including chemical structure, intended mechanism of action (MOA), and solubility.
- Specific Research Questions: A clear outline of your study objectives, desired endpoints, and any preliminary in vitro or in vivo data.
- Regulatory & Safety Information: Relevant safety data or regulatory considerations for your compound, if available.
- Final Deliverables: Upon project completion, you will receive:
- Comprehensive Study Reports: Detailed documentation of experimental protocols, raw data, statistical analyses, and scientific conclusions.
- Raw and Analyzed Data Sets: All primary data collected during the study, provided in user-friendly formats for your internal analysis.
- Detailed Interpretation of Results: Expert insights into the significance of your findings and their implications for your compound's development.
- Estimated Timeframe: The typical timeframe for our Postoperative Pain Models service ranges from 8 to 16 weeks, depending on the complexity of the study design, the number of compounds, and the specific models employed. Larger animal studies or those requiring extensive biomarker analysis may extend this duration.
Why Choose Us?
Choosing CBL for your postoperative pain research means partnering with a leader in the field, renowned for scientific rigor, translational excellence, and an unwavering commitment to client success. Our two decades of specialized experience ensure that your project benefits from unparalleled precision, predictability, and a true collaborative spirit.
- Translational Rigor: Our models are meticulously validated against clinical endpoints, ensuring that preclinical findings have a higher likelihood of translating to human efficacy. We understand the nuances of pain assessment in various species and apply robust statistical analyses.
- Comprehensive Phenotyping: Beyond basic pain thresholds, we employ a multi-modal assessment strategy, including behavioral assays, biomarker analysis, and electrophysiology, to capture the full spectrum of pain-related deficits.
- Customization and Flexibility: Each therapeutic candidate is unique. We tailor models, endpoints, and study designs to perfectly align with your specific research questions and drug mechanism of action.
- State-of-the-Art Facilities: Our laboratories are equipped with advanced instrumentation and imaging capabilities, supporting both standard and novel readouts.
- Expert Scientific Consultation: Our dedicated team of PhD-level pain scientists provides unparalleled guidance from study conceptualization through data interpretation.
Customer Reviews
"Unmatched Reproducibility. Using CBL's postoperative pain models in our research has significantly improved the reproducibility of our preclinical analgesic studies, allowing us to generate reliable data and confidently advance our lead compounds." 2024, Mar***n B.
"Translational Insights. CBL's expertise in pig models provided invaluable translational insights for our topical pain therapy, helping us understand local efficacy and systemic exposure in a highly relevant large animal system before moving to human trials." 2023, J***a S.
"Comprehensive Data. The detailed behavioral and biomarker analysis provided by CBL's Postoperative Pain Models service gave us a complete picture of our compound's mechanism of action, far exceeding the standard assessments we'd received elsewhere." 2024, P***l R.
Experience the Advantage - Get a Quote Today and discuss how our expertise can accelerate your pain research.
Postoperative Pain Models
Our comprehensive suite of postoperative pain models at CBL is meticulously developed and validated to offer high fidelity to the clinical scenario, ensuring the translational relevance of your findings. We specialize in models that address various facets of post-surgical pain:
- Incisional Pain Models
These are the most commonly employed models, mimicking the direct tissue trauma of surgery.
- Paw Incision Model (e.g., Plantar Incision Model / Brennan Model): Considered a gold standard for preclinical studies of incisional pain, this widely utilized and highly reproducible model involves a surgical incision on the plantar surface of the hind paw, often through the skin and flexor digitorum brevis muscle. It is excellent for evaluating acute post-surgical pain, the initial inflammatory response, and is particularly well-suited for the development of non-opioid analgesics due to its ability to induce relevant peripheral and central nervous system alterations.
- Abdominal Incision Model: Replicates visceral and somatic pain components associated with abdominal surgery, often used for assessing pain after laparotomy or hernia repair.
- Translational Large Animal Models (e.g., Pig Models): For advanced translational studies, we also employ larger animal models such as pigs. These models offer significant physiological and anatomical similarities to humans, making them invaluable for evaluating local and topical treatments, as well as assessing the efficacy of nerve blocks, thereby advancing pain management strategies closer to clinical application.
- Neuropathic Components of Postoperative Pain
Surgical procedures, particularly those involving nerve manipulation or transection, can lead to post-surgical neuropathic pain. Our models accurately reflect these conditions:
- Spinal Nerve Ligation (SNL) / Chronic Constriction Injury (CCI) Models with Surgical Overlay: While primarily neuropathic, these can be adapted or combined with incisional models to represent mixed pain states, common in certain surgical contexts (e.g., spinal surgery, amputations).
- Specific Nerve Transection/Compression Models: Mimic damage to particular nerves during surgery, allowing for investigation of targeted neuropathic pain mechanisms.
What We Can Offer
At CBL, our postoperative pain models service is built upon a foundation of scientific excellence and tailored solutions to meet the precise needs of biology experts and drug developers. We are committed to accelerating your research with robust, reliable, and clinically relevant data.
- Comprehensive Model Portfolio: Access to a diverse range of meticulously validated postoperative pain models, from rodent incisional models (e.g., Brennan model) to advanced translational large animal models (e.g., pig flank and leg incision models), ensuring the optimal fit for your specific research question.
- Customized Study Design: Tailored experimental paradigms and endpoint selection that are optimized to your compound's unique mechanism of action and therapeutic goals, maximizing the efficiency and relevance of your preclinical studies.
- High-Quality, Reproducible Data: Strict adherence to well-established protocols and Quality-by-Design (QbD) principles ensures the generation of highly reproducible and statistically robust efficacy data, crucial for informed decision-making.
- Multi-Modal Phenotypic Assessment: In-depth evaluation beyond basic pain thresholds, including behavioral assays, comprehensive biomarker analysis (e.g., inflammatory mediators, neuropeptides), and in vivo electrophysiology, providing a holistic understanding of your compound's effect.
- Expert Scientific Partnership: Direct collaboration with our PhD-level pain scientists throughout the entire project lifecycle, offering unparalleled consultation from experimental design to data interpretation, ensuring insightful analysis and strategic guidance.
- State-of-the-Art Infrastructure: Utilization of advanced laboratory facilities and cutting-edge instrumentation, supporting both standard and novel readouts with the highest standards of quality control.
- Commitment to Translational Success: Focus on models and methodologies that enhance the translational predictability of your findings to clinical outcomes, supporting the development of truly effective non-opioid pain therapeutics.
Related Services
To further support your comprehensive drug discovery and development efforts in pain management, CBL offers a range of complementary services:
- Acute Pain Models
- Inflammatory Pain Models
- Biomarker Development & Validation
- Neuroinflammation Studies
Ready to advance your postoperative pain research? Contact our expert team today for a confidential discussion about your specific project needs. We are eager to design the optimal preclinical strategy that translates into clinical success.
Contact Our Team for More Information and to Discuss Your Project.
- iNeuMab™ Mouse Anti-SHANK3 Monoclonal Antibody (CBP929) (Cat#: NAB-0720-Z3477)
- iNeuMab™ Anti-ApoC3 BBB Shuttle Antibody (NRZP-1022-ZP3505) (Cat#: NRZP-1022-ZP3505)
- iNeuMab™ Anti-TREM2 BBB Shuttle Antibody (NRZP-1022-ZP4114) (Cat#: NRZP-1022-ZP4114)
- iNeuMab™ Anti-TNFα BBB Shuttle Antibody (NRZP-1022-ZP4105) (Cat#: NRZP-1022-ZP4105)
- iNeuMab™ Anti-Integrin αvβ8 BBB Shuttle Antibody (NRZP-1222-ZP1218) (Cat#: NRZP-1222-ZP1218)
- iNeuMab™ Anti-Alpha Synuclein Antibody (NRP-0422-P614) (Cat#: NRP-0422-P614)
- iNeuMab™ Anti-ApoC3 BBB Shuttle Antibody (NRZP-1022-ZP3503) (Cat#: NRZP-1022-ZP3503)
- iNeuMab™ Anti-Amyloid Beta 1-15 Antibody (NRP-0422-P867) (Cat#: NRP-0422-P867)
- iNeuMab™ Anti-CD20 Antibody (NRP-0422-P1230) (Cat#: NRP-0422-P1230)
- iNeuMab™ Mouse Anti-EFNB2 Monoclonal Antibody (CBP1159) (Cat#: NAB-0720-Z4396)
- Green Fluorescent Alpha-synuclein Cell Line (Cat#: NCL2110P209)
- iNeu™ Human Motor Neurons (Cat#: NCL-2103-P71)
- Rat Olfactory Ensheathing Cells (Cat#: NRZP-1122-ZP162)
- Mouse Retinal Ganglion Cell Line RGC-5 (Cat#: NCL2110P154)
- Human Glial (Oligodendrocytic) Hybrid Cell Line (MO3.13) (Cat#: NCL-2108P34)
- Mouse Midbrain Dopaminergic Neuron Cell MN9D (Cat#: NCL2110P059)
- Rat Muller Cell (Cat#: NCL2110P040)
- iNeu™ Human Sensory Neurons (Cat#: NCL-2103-P62)
- Rat Immortalized Retinal Muller Cell Line rMC-1 (Cat#: NCL-2106-S93)
- Human Brain Astroblastoma U-87 MG (Cat#: NCL2110P117)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- VSV-eGFP (Cat#: NTA-2011-ZP20)
- Dextran, NHS Activated (Cat#: NRZP-0722-ZP124)
- AAV2 Full Capsids, Reference Standards (Cat#: NTC2101070CR)
- Mouse Parkinson disease (autosomal recessive, early onset) 7 (Park7) (NM_020569) clone, Untagged (Cat#: NEP-0621-R0133)
- Human huntingtin (HTT) (NM_002111) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0497)
- Tau Antisense Oligonucleotide (IONIS-MAPTRx) (Cat#: NV-2106-P29)
- ABCA1 Antisense Oligonucleotide (NV-2106-P27) (Cat#: NV-2106-P27)
- Mouse SOD1 shRNA Silencing Adenovirus (Cat#: NV-2106-P14)
- Rat Parkinson disease (autosomal recessive, juvenile) 2, parkin (Park2) (NM_020093) ORF clone/lentiviral particle, Myc-DDK Tagged (Cat#: NEP-0621-R0041)
- Human apolipoprotein E (APOE) (NM_000041) ORF clone, Untagged (Cat#: NEP-0421-R0232)
- Human huntingtin-associated protein 1 (HAP1) transcript variant 2 (NM_177977) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0676)
- Lenti of Mouse synuclein, alpha (Snca) transcript variant (NM_001042451) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0864)
- Human superoxide dismutase 3, extracellular (SOD3) (NM_003102) ORF clone, Untagged (Cat#: NEP-0521-R0808)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP501)
- NeuroPro™ Anti-SGSH BBB Shuttle Protein (Cat#: NRZP-0423-ZP505)
- NeuroPro™ Anti-EPO BBB Shuttle Protein (Cat#: NRZP-0423-ZP508)
- NeuroPro™ Anti-Erythropoietin BBB Shuttle Protein (Cat#: NRZP-0423-ZP499)
- NeuroPro™ Anti-PON1 BBB Shuttle Protein (Cat#: NRZP-0423-ZP507)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP498)
- NeuroPro™ Anti-idursulfase BBB Shuttle Protein (Cat#: NRZP-0423-ZP497)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP510)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP502)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP500)